Producing cell-based therapeutic products with lot-to-lot consistency from highly variable starting cell products
Cell & Gene Therapy Insights 2022; 8(10), 1277–1281
DOI: 10.18609/cgti.2022.185
Published: 2 November 2022
Viewpoint